Assistant Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine
Oncology
Dr. Andrew S. Poklepovic, MD
|
|
Give Review
Dr. Andrew S. Poklepovic works in the field of Oncology. He studied medicine at University of South Florida College of Medicine. University of South Florida College of Medicine is ranked 79/85 in Research/PrimaryCare. Andrew Poklepovic is a published MD. He has 23 publications published. The most current publication "[Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFB compensatory survival signaling." He is registered with Medicare.
Publications
- OSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood Brain Barrier: Implications for Anti-Cancer Therapies.
- Differential regulation of autophagy and cell viability by ceramide species.
- Nexavar/Stivarga and Viagra Interact to Kill Tumor Cells.
- Regulation of OSU-03012 Toxicity by ER Stress Proteins and ER Stress-Inducing Drugs.
- PDE5 inhibitors enhance Celecoxib killing in multiple tumor types.
- Outcome of early clinical trials of the combination of hydroxychloroquine with chemotherapy in Cancer.
- Sorafenib/Regorafenib and Lapatinib interact to kill CNS tumor cells.
- PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells.
- Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary Cancer cells.
- Pazopanib and HDAC inhibitors interact to kill sarcoma cells.
- HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells.
- Automated determination of metastases in unstructured radiology reports for eligibility screening in oncology clinical trials.
- Sorafenib/Regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells.
- Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis resistant mammary and brain Cancer stem cells thereby enhancing the response to a...
- Erratum to: Phase I trial of bortezomib and dacarbazine in Melanoma and soft tissue sarcoma.
- Phase I trial of bortezomib and dacarbazine in Melanoma and soft tissue sarcoma.
- Poly(ADP-ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Mammary Tumors.
- Sorafenib and pemetrexed toxicity in Cancer cells is mediated via SRC-ERK signaling.
- Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
- Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-XL and MCL-1.
- Population-based risk factors and resource utilization for HCC: US perspective.
- [Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling.
Schools
University of South Florida College of Medicine
Vcu Health System
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Virginia Commonwealth University Health System -
University of South Florida College of Medicine
Drug Facts
| NPI NUMBER | 1356550800 | |
| NPPES Provider LastName | POKLEPOVIC | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 232985051 | |
| NPPES Provider State | VA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 384.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 57.0 | |
| Percent Opioid Claims | 14.84 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356550800 |
| Last Name Of The Provider | POKLEPOVIC |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
Dr. Joshua J. McFarlane, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vikrant Brar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James L. Khatcheressian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine L. Salvant, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gordon D. Ginder, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Geoffrey W. Krystal, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David Riddick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah E. Gibson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. McCarty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Asit K. Paul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shejal B. Patel, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William M. Todd, MD |
|
|
Dr. Anna I. Rozaki-Sismanis, MD |
|
|
Dr. Beata Holkova, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruey-Min Lee, MD |
|
|
Dr. Masey M. Ross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adnan Siddiqui, MD |
|
|
Hui Lin, MB BS |